Key result
The Korean Medicine Daejeon Citizen Cohort (KDCC) study is a prospective cohort protocol designed to sample 2,000 adults to investigate lifestyle, genomic, and traditional Korean medicine factors.
Why the study?
Non-communicable diseases are the leading cause of death worldwide and in Korea, necessitating customised chronic disease management models based on individual traits, lifestyle factors, and clinical data.
Cohort (n=2,000)
This protocol outlines the Korean Medicine Daejeon Citizen Cohort study, which aims to develop a precise health promotion model for preventing and managing chronic diseases using traditional Korean medicine, lifestyle, and genomic data.
INTRODUCTION: Non-communicable diseases (NCDs) are the leading cause of death worldwide, including in Korea; thus, customised techniques for chronic disease management for the prevention, early diagnosis and treatment of NCDs are crucial. The Korean Medicine Daejeon Citizen Cohort (KDCC) study has been tasked with developing precise health promotion model for preventing and managing chronic diseases that considers individual traits, lifestyle factors and clinical data based on traditional Korean medicine. METHODS AND ANALYSIS: The KDCC study is a prospective cohort study of the community-based population in Korea. This study will sample 2000 adults aged 30-55 years in Daejeon area using stratified cluster sampling. The baseline survey began in 2017 and was completed in 2019, and follow-up surveys will be conducted three times every 2 years until 2025. In follow-ups, factors related to cardiovascular disease, metabolic syndrome and relevant diseases, as well as respondents' health status information, will be examined via questionnaire surveys and health examinations. DISCUSSION: The KDCC study will investigate the effects of an interaction of Korean medicine type with genome based, lifestyle and various clinical information on chronic diseases and individuals' health status using longitudinal epidemiological data. These findings are expected to inform the development of tailored health promotion programmes based on precision Korean medicine. TRIAL REGISTRATION NUMBER: KCT0004297.
No takes yet. Share an insight, caveat, or question.
Baek et al. (2020) conducted a cohort in Non-communicable diseases (n=2,000). Interaction of Korean medicine type with genome based, lifestyle and clinical information was evaluated on Effects of an interaction of Korean medicine type with genome based, lifestyle and various clinical information on chronic diseases and individuals' health status. The Korean Medicine Daejeon Citizen Cohort (KDCC) study is a prospective cohort protocol designed to sample 2,000 adults to investigate lifestyle, genomic, and traditional Korean medicine factors.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: